Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122238 · ClinicalTrials.gov registry record · Phase 4
Identifying Treatments to Motivate Smokers to Quit
A Phase 4 study of Smoking Cessation and Smoking, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 517
- Enrollment target
- 1
- Study location
NCT01122238 is a Phase 4 study of Smoking Cessation and Smoking that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 517 participants, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01122238, a Phase 4 study of Smoking Cessation and Smoking, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 517 participants
- Enrollment target
- 1
- Study location
Study Summary
At any given point in time, most smokers are not interested in making a serious quit attempt. Data suggest that 30% of smokers have no plans to quit, 30% plan to quit at some future date, 30% plan to quit in the next 6 months, and about 10% plan to quit in the next month. While \~40% of smokers make a quit attempt each year, only about 4-6% of those achieve long-term success. This means that of the more than 60 million Americans who smoke, only 1 million are able to quit each year. If we could double the number of quit attempts and maintain comparable success rates, we could double the number of individuals who will benefit from living smoke free lives. These observations underscore the need to develop interventions that increase smokers' motivation or willingness to make quit attempts, and that also increase the rate of success among those who attempt to quit. The overall goal of this proposed experiment is to identify effective interventions aimed at increasing motivation for smoking cessation, increasing quit attempts, and increasing rates of cessation success. Interventions that will be tested include: use of nicotine gum, use of nicotine patches, motivational interviewing, and smoking reduction counseling. At minimum, all participants will complete surveys about their smoking behavior that might increase their motivation to eventually quitting smoking.
Conditions Studied
Interventions
- OTHER No Intervention
- BEHAVIORAL Motivational Interviewing
- DRUG Nicotine Patch
- DRUG Nicotine Gum
- BEHAVIORAL Smoking Reduction
Study Locations (1)
Wisconsin
- University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 517 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01122238
The ClinicalTrials.gov registry entry for NCT01122238 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 517 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which No Intervention is the first listed.
NCT01122238 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01122238 about?
NCT01122238 is a clinical study titled "Identifying Treatments to Motivate Smokers to Quit". At any given point in time, most smokers are not interested in making a serious quit attempt. Data suggest that 30% of smokers have no plans to quit, 30% plan to quit at some future date, 30% plan to quit in the next 6 months, and about 10% plan to quit in the next month. While \~40% of smokers make...
What is the current status of trial NCT01122238?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 517 participants. The study started on 2010-06. Estimated completion is 2014-05.
What conditions does trial NCT01122238 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Nicotine Dependence, Motivation.
What interventions are being tested in trial NCT01122238?
The interventions under investigation include: No Intervention (OTHER), Motivational Interviewing (BEHAVIORAL), Nicotine Patch (DRUG), Nicotine Gum (DRUG), Smoking Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01122238?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01122238 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.